
Projects
This new manufacturing facility provides cGMP manufacturing capabilities with associated support operations, such as formulation, sterile filling, lyophilization and packaging of drug products for human use.
The facility produces a single product at a time on a campaign basis. The project required the demolition of an existing building to allow for the new facility to house the process suite. A separate existing building was renovated for shipping and receiving, warehouse space and a mechanical room.
The facility occupies 5,640 sq. ft. of newly constructed space and 9,220 sq. ft. of renovated space, for a total construction size of 14,860 sq. ft.